Healthcare costs in relation to increased use of preoperative renal tumour biopsies

Scandinavian Journal of Urology, Journal Year: 2025, Volume and Issue: 60, P. 66 - 72

Published: March 13, 2025

Objective: To analyse the budget impact of adopting routine renal tumour biopsy (RTB) prior to decision on surgical treatment for clinical T1 tumours in Sweden. Material and methods: This study used data from National Swedish Kidney Cancer Register including 4,109 T1N0M0 surgically treated during years 2018–2022. We modelled a gradual increase proportion preoperative RTBs over five-year period, 15.6 % removed tumors up 90 by 2029. Average costs per patient were calculated primarily using cost-per-patient database. The analyses stratified diameter: ≤40 mm (cT1a) 41–70 (cT1b). patients with benign RTB, complication rate false negative was estimated register previous research. A healthcare perspective accounted related biopsy, surgery, follow-up RTBs, complications re-biopsy cases inconclusive RTBs. Results: For cT1a, increasing 90% population reduced net annual €691,620, whilst cT1b, increased €67,630. Overall, an all cT1 projected reduce spending €623,990 annually. Conclusions: analysis suspected cell carcinoma indicates cost savings cT1a potentially tumours.

Language: Английский

Treatment Modalities and Risks of Complication for Patients With Localized Renal Cell Carcinoma Aged 75 and Older

Journal of Surgical Oncology, Journal Year: 2024, Volume and Issue: unknown

Published: Oct. 29, 2024

ABSTRACT Background and Objectives Partial (PN)/radical (RN) nephrectomy is the standard treatment for localized renal‐cell carcinoma (RCC). The potential risks of these procedures are concerns elderly. We evaluated perioperative outcomes/survival patients aged ≥ 75 years with RCC who underwent PN, RN, or thermal ablation (TA). Methods Localized undergoing PN/RN/TA (2000–2023) were retrospectively reviewed. Logistic‐regression assessed factors associated major complications. Kaplan‐Meier estimated survival. Results A total 278 (≥ years) received intervention (107RN, 101PN, 70TA) identified. Median age was 78 years. PN younger than other cohorts (77 vs. 79, p = 0.006). Patients cancer comorbidities TA PN/RN (93% 88%/76%, respectively). tumor size 4.0, 3.0, 2.6 cm in cohorts, respectively. RN had more complex masses compared to (9 7, < 0.001). Postoperative complications significantly greater among ( 0.03), but there no significant difference Clavien 3 Peripheral vascular disease (PVD) on multivariable analysis 0.03). performed at a stable rate while decreased favor TA. There RCC‐/non‐RCC‐specific survival modalities. Conclusions It important make informed decisions about treating elderly reduce morbidity/mortality. PVD could be determining factor favoring amenable tumors.

Language: Английский

Automatic identification and classification of pediatric glomerulonephritis on ultrasound images based on deep learning and radiomics

Journal Of Big Data, Journal Year: 2024, Volume and Issue: 11(1)

Published: Nov. 16, 2024

Language: Английский